Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have been wondering about this. What is the specific benefit of having a bedside device if you have a robot that does not require you to be at bedside to begin with?
Not trying to put down Transenterix, just would like to know what the rationale behind it is.
I think as well that this has more to do with TRXC than Titan.
I listened to their conference call, which would not instill much confidence in me if I was an investor there. A lot of talk about minor technical issues that need be resolved, without any specifics despite being questioned on it multiple times, except to say that the considerable delay is the result of these minor issues affecting the system integration as a whole. I was left feeling like management itself did not understand the technical difficulties.
It does not feel like a minor issue to me, and I think there is a whole lot of movement behind the scenes right now, which on the surface seems related to Titan, but it probably has a lot more to do with TRXC itself.
Sure, although what is considered bad news and good news differs from person to person as we have seen on this board recently (like as been mentioned, facial expressions at the opening bell of the TSX). For this stock to tank, they have to do something like XRTC, which would be a surprise to me.
From a TA perspective using L.A Little's neoclassical approach based on demand and supply (and not things like moving averages and so forth), then if SPORT is on track, back to the top of the range seems very feasible at 2.5 in the short term, since we're now at the lower part of the range.
Great news...and we might see a breakout building a new range above 2.5, but that may not come until early next year.
Bad news, and we'll build a lower range below this price point with a bottom of around 1.5.
Right, and if so, street cred points will be handed out at that point. But thanks for the info...if correct...
It feels like they are trying salvage what's left of TRXC, trying to turn things around with mimicking choices made by Titan in the past. But time will tell. Hope both companies will turn out to be a good investment in the end.
Exactly.
Wrong, I heard Elvis will replace Paul LaViolette's place at the board of TRXC.
But since we're speculating, might this not have more to do with TRXC pushing forward the submission date to the FDA, hoping to draw on the expertise of Ximedica? In other words, it may have more to do with the recent failures of TRXC than anything with Titan.
Sure, I'm sure he will if there's something to add for longer term investors. Let's see how it plays out over the next few months. TA is not an exact science, but can provide some good indications even ahead of news in my experience, penny stocks or otherwise.
I agree. It's pretty much the bottom line.
Not sure about all this speculation on Ximedica and LV Life Sciences. As you mentioned, it seems far too late for interference with development.
Fact is, the biggest competitor of Titan whose main advantage was being a little bit ahead of Titan in terms of commercialization no longer is. Sounds like a pretty good situation to me, and I don't think this news has fully sunk in yet in the investor community (and share prices).
Either way, as long as they are on schedule and tissue testing is progressing as planned, things look pretty bright.
Well..if they said it`s Nov 6 in an email, and that was the case, I would not be surprised if it shows up after hours today, espeically since it looks like they were busy this morning at the TSX.
Good..it should hold up..if not get a boost from the delay of the Surgibot. If they announce they are still on track, we're golden...
TRXC taking a hit this morning...how is titan doing? I only have delayed quotes on it.
It certainly looks like they're putting all their eggs in one basket and burning through cash quickly with their development and hiring.
The partnership with Ximedica shields Titan from a lot of such risks and expenditures I think.
I would be pretty nervous owning TRXC right now with that delay, but it could be a boost to Titan. Were the low earnings of TRXC expected?
Keep in mind the TA projection to 4-4.25 takes several months to play out if correct.
But back to the old highs..maybe sooner.
I rather have bad newsflow from Titan than those kinds of surprises.
Technical analysis of TITXF.
As I mentioned last week, I asked L.A. Little from Technical Analysis Today, a site I am a member on, to have a look at Titan, which he did yesterday.
It can be found here (at 20:10):
Sounds like a great average entry price. I hope to be at those percentage levels in a few months!
A lot has to go right, and we don't know how much pain is ahead, especially for new investors who did not buy in at the lowest levels.
I'm willing to stick out a 50% drop, so I'm very optimistic and in this for the long haul. I don't think we'll see those levels again, but you need to mentally prepare yourself.
It's not impossible, but like I said, it would be best case scenario, including not being taken over before that (which I hope does not happen).
It would also mean that the bigger hospitals get rid of their davinci's and replace them with a one port for it to be a market share grab. That won't happen too quickly.
More likely, these hospitals will first add SPORT to their arsenal.
But if Titan ever gets to expanding its product line, or comes out future generations of the SPORT, I could see this best case scenario playing out, but we're still a long way from that.
The good thing about the SPORT is that they don't need to take a marketshare from intuitive to be successful.
If they actually start doing that, however, it means they would have become the second largest player, and this thing would go over a 100.
Best case scenario, of course, but not impossible.
I added 25% more to my position today and I am now pretty much where I want to be. Ready to ride the news this week and everything else next year.
These articles have probably already been posted before, but they were new to me. I found them very informative, including the strong partnership with Ximedica, the use of computer simulation and their plans to use them in a training program for surgeons.
So in case they were not posted before, or for other newer investors like me:
http://www.mdtmag.com/articles/2014/04/drawing-board-or-part-i
http://www.mdtmag.com/articles/2014/04/drawing-board-or-part-ii
Actually, just remembered I asked the technician to have a look at it back in July when I was first considering buying. He compares it with TRXC as well, which I was also interested in at the time (not anymore).
The old youtube video is here (start at 19:35):
Thanks.
As far as the technicals on the chart, it does look like we are currently testing the monthly highs on the long term charts dating all the way back to 2011, but I expect they will hold given how close we are to 2015. Too many will be too afraid to sell now except for maybe some weak hands.
I have asked a technical analysis specialist to have a look at TITXF and asked him to discuss it in his Youtube broadcasts next week. Will post the link next week.
I agree. On top of that, it always struck me how Titan does not operate as the typical start-up company. In many ways, it seems the company is born out of dissatisfaction among medical specialists with the existing lack of competition and the limitations of robotics that are on the market currently.
This is a strength in my opinion as it will lead to an excellent product selling itself, although quite frustrating for those wishing for more hype, which the current culture of the company does not appear to promote. But this is also exactly why the line-up of names surgeon advisory is impressive, and they are serious about what needs to be achieved. I think many in the current surgical board will feel their goals are achieved having a new product in the market that works better and having more competition in the market (regardless of whom will ultimately own the SPORT). If they manage to do that, it will turn out okay for investors either way.
In the meanwhile, long on TITXF. I'm a new investor with 10k shares.